Other Species / Isoforms
  KCT2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
N75
VNALTHENQTKPSIS
0 1
KCT2 (human) VNALTHENQTKPSIS N75
KCT2 (mouse) VVVTAPGnHTSPSVS N68-ng
KCT2 (rat) TPPAVPENYTKPSVS N65
-
gap
0 6
KCT2 (human) gap -
KCT2 (mouse) EDINIAIsKESRRFR S165-p
KCT2 (rat) DNVNIEIsRESRRFR S163-p
Y175-p
TLEENRGyMEIEQSV
0 1
KCT2 (human) TLEENRGyMEIEQSV Y175-p
KCT2 (mouse) gap -
KCT2 (rat) gap -
S229-p
KIFLLVQsRKWRDGL
0 4
KCT2 (human) KIFLLVQsRKWRDGL S229-p
KCT2 (mouse) KIFLLVQsRKWRDGL S223-p
KCT2 (rat) KIFLLVQSRKWRDGL S221
K239-ub
WRDGLCSktVEyHRL
Upstream
0 33
Treatment
  • vorinostat
KCT2 (human) WRDGLCSktVEyHRL K239-ub
KCT2 (mouse) WRDGLCSkTVEyHRL K233-ub
KCT2 (rat) WRDGLCSKTVEYHRL K231
T240-p
RDGLCSktVEyHRLD
Upstream
0 1
Treatment
  • dasatinib
KCT2 (human) RDGLCSktVEyHRLD T240-p
KCT2 (mouse) RDGLCSkTVEyHRLD T234
KCT2 (rat) RDGLCSKTVEYHRLD T232
Y243-p
LCSktVEyHRLDQNV
Upstream
0 42
Treatment
  • dasatinib
KCT2 (human) LCSktVEyHRLDQNV Y243-p
KCT2 (mouse) LCSkTVEyHRLDQNV Y237-p
KCT2 (rat) LCSKTVEYHRLDQNV Y235
S256-p
NVNEAMPsLkItNDy
Upstream
0 8
Treatment
  • dasatinib
KCT2 (human) NVNEAMPsLkItNDy S256-p
KCT2 (mouse) NVNEAMPSLkITNDy S250
KCT2 (rat) NVNEAMPSLKITNDY S248
K258-ub
NEAMPsLkItNDyIF
0 6
KCT2 (human) NEAMPsLkItNDyIF K258-ub
KCT2 (mouse) NEAMPSLkITNDyIF K252-ub
KCT2 (rat) NEAMPSLKITNDYIF K250
T260-p
AMPsLkItNDyIF__
0 1
KCT2 (human) AMPsLkItNDyIF__ T260-p
KCT2 (mouse) AMPSLkITNDyIF__ T254
KCT2 (rat) AMPSLKITNDYIF__ T252
Y263-p
sLkItNDyIF_____
0 16
KCT2 (human) sLkItNDyIF_____ Y263-p
KCT2 (mouse) SLkITNDyIF_____ Y257-p
KCT2 (rat) SLKITNDYIF_____ Y255